EYLEA Trademark

Trademark Overview

On Tuesday, January 4, 2011, a trademark application was filed for EYLEA with the United States Patent and Trademark Office. The USPTO has given the EYLEA trademark a serial number of 85209921. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, April 23, 2022. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The EYLEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions
eylea

General Information

Serial Number85209921
Word MarkEYLEA
Filing DateTuesday, January 4, 2011
Status800 - REGISTERED AND RENEWED
Status DateSaturday, April 23, 2022
Registration Number4100104
Registration DateTuesday, February 14, 2012
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 3, 2011

Trademark Statements

Description of MarkThe mark consists of the word "EYLEA" and an eye design to the left of the word "EYLEA". The word "EYLEA" is in the color dark blue. With respect to the eye design, there are two thick crescent shapes facing each other on the left and the right. The crescent shape on the left is the color dark blue. The crescent shape on the right is the color yellow. In between the two crescent shapes are a series of light blue squares with a dark blue circle in the middle.
Goods and ServicesPharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions
Indication of Colors claimedThe color(s) dark blue, light blue, and yellow is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 7, 2011
Primary Code005
First Use Anywhere DateMonday, November 21, 2011
First Use In Commerce DateMonday, November 21, 2011

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Friday, January 7, 2011NEW APPLICATION ENTERED
Friday, January 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 8, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Sunday, March 27, 2011ASSIGNED TO EXAMINER
Monday, March 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 3, 2011PUBLISHED FOR OPPOSITION
Tuesday, May 3, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 23, 2011TEAS STATEMENT OF USE RECEIVED
Wednesday, November 23, 2011USE AMENDMENT FILED
Tuesday, December 6, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 14, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, December 16, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 9, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, February 14, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, January 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 14, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 5, 2018TEAS SECTION 8 & 15 RECEIVED
Friday, January 6, 2012ASSIGNED TO LIE
Tuesday, January 10, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 25, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 25, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, December 23, 2021TEAS SECTION 8 & 9 RECEIVED
Saturday, April 23, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, April 23, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 25, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, February 14, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, April 23, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, April 24, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

eylea pharmaceutical preparations diseases conditions ophthalmic ophthalmics namely treatment